The "obesity paradox": Does it persist among Israeli patients with decompensated heart failure? a subanalysis of the heart failure survey in Israel (HFSIS)

Journal of Cardiac Failure

Volumn 18, Issue 1, 2012, Pages 62-67

  Schwartzenberg, Shmuel ^a,b   Benderly, Michal ^c   Malnick, Stephen ^a,b   George, Jacob ^a,b   Goland, Sorel ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

congestive heart failure; Obesity paradox; reverse epidemiology

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CORRELATION ANALYSIS; DECOMPENSATED HEART FAILURE; DEMOGRAPHY; DYSLIPIDEMIA; FEMALE; HEALTH SURVEY; HEART FAILURE; HUMAN; HYPERTENSION; ISRAEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

AGED; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; FEMALE; HEALTH SURVEYS; HEART FAILURE; HOSPITALIZATION; HUMANS; ISRAEL; MALE; OBESITY; SURVIVAL ANALYSIS;

EID: 84855669656     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.09.013     Document Type: Article

References (32)

1. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
2. D.M. Lloyd-Jones, M.G. Larson, and E.P. Leip Lifetime risk for developing congestive heart failure: the Framingham Heart Study Circulation 106 2002 3068 3072 (Pubitemid 35440290)
3. M.A. Alpert Obesity cardiomyopathy: pathophysiology and evaluation of the clinical syndrome Am J Med Sci 321 2001 225 236 (Pubitemid 32275931)
4. S. Kenchaiah, J.C. Evans, and D. Levy Obesity and the risk of heart failure N Engl J Med 347 2002 305 313 (Pubitemid 34815352)
5. C. Davos, W. Dowhner, and M. Rauchhaus Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity J Cardiac Fail 9 2003 29 35 (Pubitemid 36356699)
6. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J Am Coll Cardiol 53 2009 1925 1932
7. C.J. Lavie, A.F. Osman, R.V. Milani, and M.R. Mehra Body composition and prognosis in chronic systolic heart failure: the obesity paradox Am J Cardiol 91 2003 891 894 (Pubitemid 36363743)
8. A.L. Clark, G.C. Fonarow, and T.B. Horwich Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited J Card Fail 17 2011 374 380
9. T.B. Horwich, G.C. Fonarow, and M.A. Hamilton The relationship between obesity and mortality in patients with heart failure J Am Coll Cardiol 38 2001 789 795 (Pubitemid 32835754)
10. K. Kalantar-Zadeh, G. Block, T. Horwich, and G.C. Fonarow Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure J Am Coll Cardiol 43 2004 1439 1444 (Pubitemid 38496352)
11. S. Kenchaiah, S. Pocock, D. Wang CHARM Investigators Body mass index and prognosis in patients with chronic heart failure. Insights from Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Circulation 116 2007 627 636 (Pubitemid 47356347)
12. F. Gustafsson, C.B. Kragelund, C. Torp-Pedersen DIAMOND Study Group Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function Eur Heart J 26 2005 58 64 (Pubitemid 40221124)
13. M. Cicoira, A. Maggioni, R. Latini Val-HeFT Investigators Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial Eur J Heart Fail 9 2007 397 402 (Pubitemid 46454390)
14. J.P. Curtis, J.G. Selter, and Y. Wang The obesity paradox. Body mass index and outcomes in patients with heart failure Arch Intern Med 165 2005 55 61 (Pubitemid 40096082)
15. J.R. Kapoor, and P.A. Heidenreich Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship Am Heart J 159 2010 75 80
16. C. Adamopoulos, P. Meyer, and R.V. Desai Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study Eur J Heart Fail 13 2011 200 206
17. L. Frankenstein, C. Zugck, and M. Nelles The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders Eur J Heart Fail 11 2009 1189 1194
18. M. Garty, A. Shotan, S. Gottlieb HFSIS Steering Committee and Investigators The management, early and one year outcome in hospitalized patients with heart failure: a national heart failure survey in Israel - HFSIS 2003 Isr Med Assoc J 9 2007 227 233 (Pubitemid 46692035)
19. B.S. Lewis, A. Shotan, S. Gottlieb HFSIS Investigators Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel nationwide heart failure survey Isr Med Assoc J 9 2007 234 238 (Pubitemid 46692036)
20. S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053 (Pubitemid 27158249)
21. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl. 1 2002 S1 266
22. A.V. Chobanian, G.L. Bakris, H.R. Black Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252 (Pubitemid 37553153)
23. A. Oreopoulos, R. Padwal, and K. Kalantar-Zadeh Body mass index and mortality in heart failure: a meta-analysis Am Heart J 156 2008 13 22 (Pubitemid 351862293)
24. C.J. Lavie, and H.O. Ventura Weighing in on obesity and the obesity paradox in heart failure J Card Fail 17 2011 381 383
25. T.B. Horwich, M.A. Hamilton, W.R. Maclellan, and G.C. Fonarow Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure J Card Fail 8 2002 216 224
26. T.B. Horwich, and G.C. Fonarow Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS Semin Dial 20 2007 549 553
27. G. Güder, S. Frantz, and J. Bauersachs Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors Circ Heart Fail 2 2009 563 571
28. S.D. Anker, A. Negassa, and A.J. Coats Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study Lancet 361 2003 1077 1083 (Pubitemid 36369559)
29. D.S. Lee, P.C. Austin, and J.L. Rouleau Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587 (Pubitemid 37443288)
30. M. Gheorghiade, W.T. Abraham, N.M. Albert OPTIMIZE-HF Investigators and Coordinators Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226 (Pubitemid 44708052)
31. C.E. Raphael, Z.I. Whinnett, and J.E. Davies Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure Heart 95 2009 56 62
32. M. Rauchhaus, A.J. Coats, and S.D. Anker The endotoxin-lipoprotein hypothesis Lancet 356 2000 930 933